Zuclopenthixol

Amber

Brand Name(s):Clopixol

Indication:All licensed indications

Rationale:

Considered:Jun-09

Review Date:Jul-20

Comments:
NICE CG178
Psychosis and schizophrenia in adults: treatment and management
Full details at:https://www.nice.org.uk/guidance/cg178/resources/guidance-psychosis-and-schizophrenia-in-adults-treatment-and-management-pdf
Feb 2014
…………………………
Psychosis and schizophrenia in children and young people
National Clinical Guideline Number CG155
January 2013
Guidance available at: http://www.nice.org.uk/nicemedia/live/14021/62392/62392.pdf
…………………………
The specialist service will ensure the patient is fully established on treatment before requesting transfer to Primary care.

When requesting transfer of care, specialist services will send a letter to the G.P explaining which shared care arrangement the request was being made under and provide any other guidance or direction relating to the drug and review process.

The patient will be asked to make arrangements with their GP for continued supply.

Shared Care Protocol for the Prescribing of Antipsychotics
Doncaster & Bassetlaw Area Prescribing Committee March 2010

Antipsychotic use may be associated with an increased risk of VTE. At present there are insufficient data available to determine any difference in risk between atypical and conventional antipsychotics, or between individual drugs. All possible risk factors for VTE should be identified before and during antipsychotic treatment and preventive measures undertaken

MHRA Drug safety update Volume 2 Issue 11 June 2009